GD
Given Douglas B
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Given Douglas B, Director. Insider active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 12 filings have been published. Split: 0 buy · 7 sells. Total volume traded: €1.1m. Activity tracked since 22 June 2021. The latest transaction was disclosed on 16 December 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Given Douglas B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
5,000 shares@ US$21.905.1% of flowCommon StockSEC:0001628280-24-051924:0
1,100 shares@ US$38.551.9% of flowCommon StockSEC:0001628280-24-001425:1
1,811 shares@ US$37.763.0% of flowCommon StockSEC:0001628280-24-001425:0
14,987 shares@ US$25.4116.9% of flowCommon StockSEC:0001628280-23-041962:0
6,500 shares@ US$40.9011.8% of flowCommon StockSEC:0001628280-23-016560:0
875 shares@ US$32.621.3% of flowCommon StockSEC:0001209191-23-014275:0
7,867 shares0Common StockSEC:0001209191-23-003075:0
6,400 shares0Common StockSEC:0001209191-22-002590:0
655 shares0Common StockSEC:0001209191-21-071563:0
5,000 shares@ US$65.2419.3% of flowCommon StockSEC:0001209191-21-055474:0
4,500 shares@ US$89.2123.5% of flowCommon StockSEC:0001209191-21-043051:0
35,000 sharesCommon StockSEC:0001209191-16-088054:0
About Given Douglas B
GIVEN DOUGLAS B is a Director of Arrowhead Pharmaceuticals, INC. and ARROWHEAD RESEARCH CORP. He has 12 filings in total, and across the 12 recent filings we track, sales total 1085497 EUR between 2016-01-04 and 2024-12-18, with the dominant transaction nature shown as sale.